Sakai S - Search Results

1

Prognostic factors for short-term survival in patients with stage IV non-small cell lung cancer.

Ando M, Ando Y, Sugiura S, Minami H, Saka H, Sakai S, Shimokata K, Hasegawa Y. Ando M, et al. Among authors: sakai s. Jpn J Cancer Res. 1999 Feb;90(2):249-53. doi: 10.1111/j.1349-7006.1999.tb00740.x. Jpn J Cancer Res. 1999. PMID: 10189897 Free PMC article.

2

Therapeutic drug monitoring of etoposide in a 14-day infusion for non-small-cell lung cancer.

Ando Y, Minami H, Saka H, Ando M, Sakai S, Shimokata K. Ando Y, et al. Among authors: sakai s. Jpn J Cancer Res. 1996 Feb;87(2):200-5. doi: 10.1111/j.1349-7006.1996.tb03159.x. Jpn J Cancer Res. 1996. PMID: 8609070 Free PMC article. Clinical Trial.

3

Is there a circadian variation in plasma concentrations of etoposide given by prolonged continuous infusion?

Ando Y, Minami H, Sakai S, Shimokata K. Ando Y, et al. Among authors: sakai s. Cancer Chemother Pharmacol. 1996;37(6):616-8. doi: 10.1007/s002800050438. Cancer Chemother Pharmacol. 1996. PMID: 8612319

4

Therapeutic drug monitoring in 21-day oral etoposide treatment for lung cancer.

Ando Y, Minami H, Saka H, Ando M, Sakai S, Shimokata K. Ando Y, et al. Among authors: sakai s. Jpn J Cancer Res. 1996 Aug;87(8):856-61. doi: 10.1111/j.1349-7006.1996.tb02111.x. Jpn J Cancer Res. 1996. PMID: 8797893 Free PMC article.

5

Acceptability of patients with brain metastases for clinical trials of chemotherapy for metastatic non-small-cell lung cancer.

Ando Y, Sugiura S, Ando M, Minami H, Nomura F, Sakai S, Shimokata K. Ando Y, et al. Among authors: sakai s. Am J Clin Oncol. 1996 Oct;19(5):478-82. doi: 10.1097/00000421-199610000-00010. Am J Clin Oncol. 1996. PMID: 8823475

6

Pharmacokinetic study of carboplatin given on a 5-day intravenous schedule.

Ando Y, Minami H, Saka H, Ando M, Sugiura S, Sakai S, Shimokata K. Ando Y, et al. Among authors: sakai s. Jpn J Cancer Res. 1997 May;88(5):517-21. doi: 10.1111/j.1349-7006.1997.tb00412.x. Jpn J Cancer Res. 1997. PMID: 9247610 Free PMC article. Clinical Trial.

7

A phase II study of carboplatin and prolonged administration of oral etoposide in patients with small-cell lung cancer.

Minami H, Saka H, Sakai S, Yamamoto M, Shimokata K. Minami H, et al. Among authors: sakai s. Acta Oncol. 1997;36(7):765-9. doi: 10.3109/02841869709001352. Acta Oncol. 1997. PMID: 9490098 Clinical Trial.

8

Prognostic value of pleural effusion in patients with non-small cell lung cancer.

Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K. Sugiura S, et al. Among authors: sakai s. Clin Cancer Res. 1997 Jan;3(1):47-50. Clin Cancer Res. 1997. PMID: 9815536

9

Pharmacological analysis of etoposide in elderly patients with lung cancer.

Ando M, Minami H, Ando Y, Sakai S, Shimono Y, Sugiura S, Saka H, Shimokata K, Hasegawa Y. Ando M, et al. Among authors: sakai s. Clin Cancer Res. 1999 Jul;5(7):1690-5. Clin Cancer Res. 1999. PMID: 10430070 Clinical Trial.

10

Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer.

Ando M, Ando Y, Hasegawa Y, Shimokata K, Minami H, Wakai K, Ohno Y, Sakai S. Ando M, et al. Among authors: sakai s. Br J Cancer. 2001 Nov 30;85(11):1634-9. doi: 10.1054/bjoc.2001.2162. Br J Cancer. 2001. PMID: 11742480 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,728 results

Search Page

Filters